Anti-Spike RBD Antibody (Cilgavimab)
Catalog No.
F1025
Anti-Spike RBD Antibody (Cilgavimab)
Featured Products
Cilgavimab (AZD-1061; COV2-2130) is a humanized monoclonal antibody targeting SARS-CoV-2 that can be combined with tixagevimab to form the monoclonal antibody combination AZD7442. Cilgavimab has a protective effect against SARS-CoV-2 infection in a mouse model.
148.82 kDa
Dry ice
2420563-99-9
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
COV2-2130, Cilgavimab, AZD1061
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Spike RBD
Please avoid freeze-thaw cycles.